Skip to content

Clinical trials

Phase 1/2 Prostatic Neoplasms trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Neoplasms Phase: Phase 1/2 Status: Unknown status Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20053
20061
20081
20091
20101
20112
20131
20142
20164
20172
20183
20191
20201
20212
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status32

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sunnybrook Health Sciences Centre3
AHS Cancer Control Alberta1
Adamis Pharmaceuticals Corporation1
Arno Therapeutics1
Center for Molecular Medicine1
Cytogen Corporation1
Eutilex1
First Affiliated Hospital of Chengdu Medical College1
Guangzhou University of Traditional Chinese Medicine1
Herbert Irving Comprehensive Cancer Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms32
Neoplasms4
Adenoviridae Infections2
Neoplasm Metastasis2
Prostatic Diseases2
Carcinoma, Hepatocellular1
Carcinoma, Non-Small-Cell Lung1
Carcinoma, Renal Cell1
Colonic Neoplasms1
Esophageal Neoplasms1

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.